A Phase 2 Randomized, Placebo-controlled, Double-blind Dose-ranging Study to Evaluate the Efficacy, Safety and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus

Project: Research

Project Details

Project Description

ERM Reference Number: 90455
Monash Health Reference: RES-22-0000-661A
StatusActive
Effective start/end date11/04/23 → 10/04/28